Creative Medical Technology Holdings, Inc. Stock Other OTC
Equities
CELZ
US22529Y2000
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 563K 770K | Capitalization | 5.96M 8.16M |
---|---|---|---|---|---|
Net income 2024 * | -6M -8.21M | Net income 2025 * | -6M -8.21M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
-0.94
x | P/E ratio 2025 * |
-1.17
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.33% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 63 | 16-05-17 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |